COVID-19 UPDATE: Regenexx is committed to the health and safety of our patients. You may now be seen in clinic or via telemedicine for virtual/online or phone visits.
LEARN MORE
Our physicians are available via telemedicine to continue to give you the care you need during this difficult time. Learn more.

Problems with Meniscus Allografts Surface

By /

Receive a Regenexx® Patient Info Packet by email and learn why it's a superior regenerative solution.

By submitting the form, you are agreeing that you read and consent to our Privacy Policy. We may also contact you via email, phone, and other electronic means to communicate information about our products and services. We do not sell, or share your information to third party vendors.

meniscus allograft replacement surgery risks

The knee meniscus is a spacer that protects the knee cartilage. Regrettably, we still have a surgical culture that cuts out parts of a torn meniscus, despite research demonstrating that removing parts of the meniscus leads to more knee arthritis. To try and fix the problem of a surgically removed or degenerated meniscus, meniscus allografts have been used. These are cadaver meniscus parts that are implanted surgically in the knee to provide a new spacer to protect cartilage. These are usually frozen until ready to be used. However, a recent research study calls into question whether the common freezing method used kills the important cells in the meniscus that would allow it to survive in the knee. Meniscus tissue is made of of living cells that are needed to repair the meniscus from damage caused by normal wear and tear. Remove the cells from the equation, and the spacer will quickly get chewed up by normal activities because it doesn’t have the ability to fix normal damage. This study demonstrated that the cells inside these frozen meniscus implants were about 50 times more “apoptotic” (meaning dead or dying) than a fresh meniscus. The upshot? One of the meniscus allograft replacement surgery risks is that the meniscus tissue won’t “take” and will be quickly torn. A meniscus transplant that will survive long-term in the body needs viable cells. An alternate route is to augment the decellularized meniscus with stem cells capable to engrafting and surviving. This has already been accomplished in an animal model. In this study, they took a meniscus where all of the cells had been removed and repopulated it with bone marrow stem cells. The researchers observed very nice biologic replacement of the original meniscus where the cells survived. In summary, this new study showed that most of the cells in a frozen cadaver meniscus of the type commonly used in meniscus allograft replacement surgery are dead or dying. This calls into question whether what we’re doing now with meniscus transplants is worth the invasive surgery.

Category: Knee, Latest News

Is Regenexx Right For You?

Request a free Regenexx Info Packet

REGENEXX WEBINARS

Learn about the #1 Stem Cell & Platelet Procedures for treating arthritis, common joint injuries & spine pain.

Join a Webinar

RECEIVE BLOG ARTICLES BY EMAIL

Get fresh updates and insights from Regenexx delivered straight to your inbox.

Subscribe to the Blog

CONTACT US

9035 Wadsworth Pkwy #1000
Westminster, CO 80021
888-525-3005

FOLLOW US

Copyright © Regenexx 2020. All rights reserved. | Privacy Policy

*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.

LinkedIn
Email